COMMUNIQUÉS West-GlobeNewswire

Cara Therapeutics Reports Positive Top-Line Data from Adaptive Phase 2/3 Trial of I.V. CR845 in Patients Undergoing Abdominal Surgery
27/06/2018
-I.V. CR845 achieved statistical significance for the study’s primary endpoint of pain relief over the 0 to 24-hour (AUC 0-24) period post-surgery for combined surgeries at the 1.0 mcg/kg dose (p=0.032)- -I.V. CR845 [...]
Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Treatment of Autoimmune Hepatitis
27/06/2018
TORONTO, June 27, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE:RVV) (OTCQB:RVVTF) (FSE:31R) ("Revive" or the "Company") , a company focused on the research, development and commercialization of novel [...]
Summit Announces PhaseOut DMD Did Not Meet Primary Endpoint
27/06/2018
Ezutromid Development to be Discontinued Summit to Focus on Advancing its Pipeline of New Mechanism Antibiotics Conference Call Scheduled for 8:00am EDT / 1:00pm BST OXFORD, United Kingdom and CAMBRIDGE, Mass., June 27 [...]
Avivagen Receives Approval from Health Canada for Use of OxC-beta™ in Companion Animal Supplements
27/06/2018
OTTAWA, Ontario, June 27, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion [...]
Aquinox Announces Topline Results of Phase 3 LEADERSHIP 301 Clinical Trial in Interstitial Cystitis/Bladder Pain Syndrome
27/06/2018
VANCOUVER, British Columbia, June 27, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), today announced that the Phase 3 LEADERSHIP 301 clinical trial evaluating once-daily, oral [...]
Healthwise Names Dr. Adam Husney President
27/06/2018
BOISE, Idaho, June 27, 2018 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, technology, and services, announced today that Adam Husney, MD, has been named President of Healthwise, effective [...]
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director
27/06/2018
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director Two new appointments follow oversubscribed $75 million (€64 million) [...]
PotNetwork Holdings, Inc. Initiates Corporate Name Change to BioTech Hemp, Inc.
27/06/2018
Company to Change Name for Closer Alignment with its Corporate Identity as a Dominant Player in the CBD Industry FT. LAUDERDALE, Fla., June 27, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC [...]
Shire plc : Rule 2.9 announcement
27/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 27 June 2018 Shire [...]
Dividend payment ex-date of AS “Latvijas Jūras medicīnas centrs”
27/06/2018
Latvia, 2018-06-27 07:52 CEST (GLOBE NEWSWIRE) -- AS “Latvijas Jūras medicīnas centrs” (LJM1R, ISIN code LV0000100741) will close the list of shareholders for dividend payment on July 2, 2018 at the end of the working [...]
ThromboGenics Plans Name Change to "Oxurion"
27/06/2018
To better reflect Company's activities and ambition to deliver best in class therapies for back of the eye disorders Press release - Regulated Information Leuven, Belgium, 27 June 2018 - ThromboGenics NV (Euronext [...]
MDxHealth's SelectMDx Test Successfully Stratifies Men
27/06/2018
NEWS RELEASE MDxHealth's SelectMDx Test Successfully Stratifies Men Who May Benefit from mp-MRI Multiple SelectMDx Clinical Study Abstracts presented at 2018 Global Prostate Congress in Frankfurt, Germany HERSTAL, [...]
Le test SelectMDx de MDxHealth classe avec succès les hommes
27/06/2018
COMMUNIQUÉ DE PRESSE Le test SelectMDx de MDxHealth classe avec succès les hommes qui peuvent bénéficier de l'IRMmp De nombreux résumés d'étude clinique de SelectMDx présentés au congrès mondial sur le cancer de la [...]
Biocartis Group NV: Study Reviewing 2,500 Performed Idylla(TM) Tests Shows Generation of Valid Results in 98.1% of Cases and Outperformance over Reference Methods
27/06/2018
PRESS RELEASE : 27 June 2018, 07:00 CEST Study Reviewing 2,500 Performed Idylla(TM) Tests Shows Generation of Valid Results in 98.1% of Cases and Outperformance over Reference Methods Mechelen, Belgium, 27 June 2018 - [...]
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director
27/06/2018
iTeos Therapeutics Expands Board of Directors with the Appointment of David Hallal as Chairman and Tim Van Hauwermeiren as an Independent Director Two new appointments follow oversubscribed $75 million (€64 million) [...]
Assure Holdings Corp. Announces Update
27/06/2018
DENVER, June 26, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH) is providing an update relating to the Management Cease Trade Order (“ MCTO ”), effective May 1, [...]
Peer-reviewed Neurology Publication on Medibio Science
27/06/2018
SYDNEY, Australia and MINNEAPOLIS, June 26, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, announces that a clinical article by Defillo et al [...]
Image Following Treatment with 177Lu-PSMA-617 Selected by Society of Nuclear Medicine and Molecular Imaging as Image of the Year
27/06/2018
Image depicts PSMA PET scans of eight patients with exceptional responses from investigator-sponsored Phase 2 study WEST LAFAYETTE, Ind., June 26, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a [...]
Neon Therapeutics Announces Pricing of Initial Public Offering
27/06/2018
CAMBRIDGE, Mass., June 26, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq:NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced the pricing of its initial [...]

Pages